Months after $100M raise, budding RTP firm acquires Duke University spinout
The deal sets the foundation for the company to establish a division that's focused on the discovery and development of gene therapies for rare diseases.
The deal sets the foundation for the company to establish a division that's focused on the discovery and development of gene therapies for rare diseases.